Access cutting-edge subarachnoid hemorrhage treatment through this clinical trial at a research site in Portland. Study-provided care at no cost to qualified participants.
Access subarachnoid hemorrhage specialists in Portland at no cost
This study follows strict safety protocols and ethical guidelines
All study-related subarachnoid hemorrhage treatment provided free
BLOCK-SAH is a phase II, multicenter, randomized, double-blinded, placebo-controlled clinical trial with a sequential parallel comparison design (SPCD) of bilateral pterygopalatine fossa (PPF) injections with 20mg ropivacaine + 4mg dexamethasone (active, PPF-block) compared to saline (placebo) for headache in survivors of aneurysmal subarachnoid hemorrhage (SAH), while monitoring intracranial arterial mean flow velocities with transcranial Doppler (TCD) peri-intervention (intervention = PPF-inje
Sponsor: University of Florida
Check if you qualify for this subarachnoid hemorrhage clinical trial in Portland, OR
If you're searching for subarachnoid hemorrhage treatment options in Portland, OR, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Portland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced subarachnoid hemorrhage specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.